Literature DB >> 24374328

Effects of sustained proNGF blockade on attentional capacities in aged rats with compromised cholinergic system.

B Yegla1, V Parikh2.   

Abstract

Disruption in nerve growth factor (NGF) signaling via tropomyosin-related kinase A (trkA) receptors compromises the integrity of the basal forebrain (BF) cholinergic system, yielding cognitive, specifically attentional, impairments in Alzheimer's disease (AD). Although normal aging is considered a risk factor for AD, the mechanisms underlying the selective vulnerability of the aging cholinergic system to trkA disruption is not clear. The levels of proNGF, a proneurotrophin that possesses higher affinity for p75 receptors, increase in aging. The present study was designed to test the hypothesis that cholinergic and attentional dysfunction in aged rats with reduced BF trkA receptors occurs due to the overactivation of endogenous proNGF signaling. We employed a viral vector that produced trkA shRNA to suppress trkA receptors in the corticopetal cholinergic neurons of aged rats. BF trkA suppression impaired animals' performance on signal trials in both the sustained attention task (SAT) and the cognitively taxing distractor version of SAT (dSAT) and these deficits were normalized by chronic intracerebroventricular administration of proNGF antibody. Moreover, depolarization-evoked acetylcholine (ACh) release and the density of cortical cholinergic fibers were partially restored in these animals. However, SAT/dSAT scores reflecting overall performance did not improve following proNGF blockade in trkA knockdown rats due to impaired performance in non-signal trials. Sustained proNGF blockade alone did not alter baseline attentional performance but produced moderate impairments during challenging conditions. Collectively, our findings indicate that barring proNGF-p75 signaling may exert some beneficial effects on attentional capacities specifically when BF trkA signaling is abrogated. However, endogenous proNGF may also possess neurotrophic effects and blockade of this proneurotrophin may not completely ameliorate attentional impairments in AD and potentially hinder performance during periods of high cognitive load in normal aging.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; acetylcholine; aging; attention; proNGF

Mesh:

Substances:

Year:  2013        PMID: 24374328      PMCID: PMC3945974          DOI: 10.1016/j.neuroscience.2013.12.042

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  72 in total

1.  Aging causes a preferential loss of cholinergic innervation of characterized neocortical pyramidal neurons.

Authors:  Maria Antonietta Casu; T P Wong; Yves De Koninck; Alfredo Ribeiro-da-Silva; A Claudio Cuello
Journal:  Cereb Cortex       Date:  2002-03       Impact factor: 5.357

2.  Processing of the native nerve growth factor precursor to form biologically active nerve growth factor.

Authors:  R H Edwards; M J Selby; P D Garcia; W J Rutter
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

3.  A role for TrkA during maturation of striatal and basal forebrain cholinergic neurons in vivo.

Authors:  A M Fagan; M Garber; M Barbacid; I Silos-Santiago; D M Holtzman
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

Review 4.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

5.  Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR.

Authors:  Carlos E Pedraza; Petar Podlesniy; Noemí Vidal; Juan Carlos Arévalo; Ramee Lee; Barbara Hempstead; Isidre Ferrer; Montse Iglesias; Carme Espinet
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

6.  Augmented prefrontal acetylcholine release during challenged attentional performance.

Authors:  Rouba Kozak; John P Bruno; Martin Sarter
Journal:  Cereb Cortex       Date:  2005-03-23       Impact factor: 5.357

Review 7.  Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection.

Authors:  Martin Sarter; Michael E Hasselmo; John P Bruno; Ben Givens
Journal:  Brain Res Brain Res Rev       Date:  2005-02

8.  Prefrontal acetylcholine release controls cue detection on multiple timescales.

Authors:  Vinay Parikh; Rouba Kozak; Vicente Martinez; Martin Sarter
Journal:  Neuron       Date:  2007-10-04       Impact factor: 17.173

9.  TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons.

Authors:  D M Holtzman; J Kilbridge; Y Li; E T Cunningham; N J Lenn; D O Clary; L F Reichardt; W C Mobley
Journal:  J Neurosci       Date:  1995-02       Impact factor: 6.167

10.  Interaction of survival and death signaling in basal forebrain neurons: roles of neurotrophins and proneurotrophins.

Authors:  Marta Volosin; Wenyu Song; Ramiro D Almeida; David R Kaplan; Barbara L Hempstead; Wilma J Friedman
Journal:  J Neurosci       Date:  2006-07-19       Impact factor: 6.709

View more
  11 in total

1.  Developmental suppression of forebrain trkA receptors and attentional capacities in aging rats: A longitudinal study.

Authors:  Brittney Yegla; Vinay Parikh
Journal:  Behav Brain Res       Date:  2017-08-10       Impact factor: 3.332

2.  Effect of red and black ginseng on cholinergic markers, presynaptic markers, and neurotrophins in the brain of aged mice.

Authors:  Mi Ra Lee; Shahnaz Begum; Chang Keun Sung
Journal:  Food Sci Biotechnol       Date:  2017-10-16       Impact factor: 2.391

3.  Transcriptomic changes in the prefrontal cortex of rats as a function of age and cognitive engagement.

Authors:  Michael R Duggan; Surbhi Joshi; Yin-Fei Tan; Michael Slifker; Eric A Ross; Mathieu Wimmer; Vinay Parikh
Journal:  Neurobiol Learn Mem       Date:  2019-06-08       Impact factor: 2.877

4.  Interactions between Aβ oligomers and presynaptic cholinergic signaling: age-dependent effects on attentional capacities.

Authors:  Vinay Parikh; Carcha S Bernard; Sean X Naughton; Brittney Yegla
Journal:  Behav Brain Res       Date:  2014-08-04       Impact factor: 3.332

Review 5.  Microglia and modifiable life factors: Potential contributions to cognitive resilience in aging.

Authors:  Michael R Duggan; Vinay Parikh
Journal:  Behav Brain Res       Date:  2021-02-25       Impact factor: 3.332

6.  Rejuvenating procholinergic treatments for cognition enhancement in AD: current challenges and future prospects.

Authors:  Brittney Yegla; Vinay Parikh
Journal:  Front Syst Neurosci       Date:  2015-01-28

7.  Mental disorders, functional impairment, and nerve growth factor.

Authors:  Fanny Helena Martins Salles; Pedro San Martin Soares; Carolina David Wiener; Thaise Campos Mondin; Paula Moraes da Silva; Karen Jansen; Luciano Dias de Mattos Souza; Ricardo Azevedo da Silva; Jean Pierre Oses
Journal:  Psychol Res Behav Manag       Date:  2016-12-22

Review 8.  The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease Neuropathology.

Authors:  Nadia Canu; Giuseppina Amadoro; Viviana Triaca; Valentina Latina; Valentina Sposato; Veronica Corsetti; Cinzia Severini; Maria Teresa Ciotti; Pietro Calissano
Journal:  Int J Mol Sci       Date:  2017-06-20       Impact factor: 5.923

9.  Dynamic interplay of frontoparietal cholinergic innervation and cortical reorganization in the regulation of attentional capacities in aging.

Authors:  Brittney Yegla; Surbhi Joshi; Jacob Strupp; Vinay Parikh
Journal:  Neurobiol Aging       Date:  2021-05-06       Impact factor: 5.133

Review 10.  Regulation of cholinergic basal forebrain development, connectivity, and function by neurotrophin receptors.

Authors:  Zoran Boskovic; Sonja Meier; Yunpeng Wang; Michael R Milne; Tessa Onraet; Angelo Tedoldi; Elizabeth J Coulson
Journal:  Health Psychol Behav Med       Date:  2019-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.